ArticleInternational journal of bioprinting2025
Advancing Modular Microfluidics: Stereolithographic 3D Printing of Reconfigurable Connectors for Bioanalytical Applications.
Article in International journal of bioprinting, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating Optical Feedback Alignment and Fluidic Control for Multiphase Flow-Assisted In Situ 3D Printing.Journal of separation science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Traditional monolithic microfluidic devices are constrained by their inability to accommodate modifications to circuit elements, necessitating complete redesign and refabrication. To address these limitations, this study introduces modular microfluidic connectors fabricated via stereolithographic (SL) 3D printing. We designed and evaluated three distinct connector types-tessellated, sponge, and solid-walled-using tailored photoresins to enhance reusability, flexibility, and sealing performance. The tessellated connectors, printed with poly(ethylene glycol) diacrylate (PEGDA, Mw ~258) and incorporating an Octet Unit cell structure, reduced the rigidity of PEGDA prints, improving reusability under moderate conditions. The sponge connectors, fabricated from a PEGDA and 2-hydroxyethyl acrylate (2-HEA, Mw ~116) blend (2-HEA-co-PEGDA), exhibited greater flexibility; however, swelling in aqueous environments may limit their long-term utility. In contrast, the solid-walled connectors, produced with commercial Asiga Soft Resin, demonstrated superior reliability and adaptability, as validated in a reconfigurable concentration gradient generator (CGG) with scalable output capabilities. Cytocompatibility tests confirmed that PEGDA-printed devices, following isopropanol (IPA) and UV post-processing, are suitable for bioanalytical applications that do not require incubation. These findings establish SL 3D printing as a promising method for developing flexible, reconfigurable microfluidic platforms, with potential uses in material synthesis, chemical analysis, and point-of-care diagnostics. While challenges related to environmental durability persist, these advances lay the foundations for developing more robust and adaptable microfluidic systems with versatile applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.